Howe & Rusling’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-35
Closed -$4K 462
2022
Q3
$4K Buy
35
+14
+67% +$1.79K ﹤0.01% 700
2022
Q2
$3K Hold
21
﹤0.01% 769
2022
Q1
$3K Sell
21
-6
-22% -$1.14K ﹤0.01% 768
2021
Q4
$5K Hold
27
﹤0.01% 661
2021
Q3
$5K Buy
27
+8
+42% +$1.33K ﹤0.01% 633
2021
Q2
$3K Hold
19
﹤0.01% 727
2021
Q1
$3K Sell
19
-3
-14% -$364 ﹤0.01% 737
2020
Q4
$2K Buy
+22
New +$2.2K ﹤0.01% 783

Other funds holding CNXC

Howe & Rusling's CNXC Position: Q4 2022 in Review

Howe & Rusling sold out of Concentrix (CNXC) in Q4 2022, closing a stake of 35 shares — an estimated $4K sold.

Howe & Rusling first reported a position in CNXC in Q4 2020 and held it in 8 quarters. The position peaked at $5K in Q4 2021. 321 funds tracked by Wall St. Rank hold CNXC as of Q4 2022.

  • Howe & Rusling reported no remaining Concentrix position as of Q4 2022 after selling out during the quarter.
  • Howe & Rusling sold 35 Concentrix shares in Q4 2022, an estimated $4K.
  • Howe & Rusling first reported a position in Concentrix in Q4 2020 and held it in 8 quarters.
  • Howe & Rusling's Concentrix position peaked at $5K in Q4 2021.
  • 321 funds tracked by Wall St. Rank held Concentrix as of Q4 2022.

Based on Howe & Rusling's 13F filing for Q4 2022, filed 15 Feb 2023.